申请人:Kind Pharmaceutical
公开号:US11021478B2
公开(公告)日:2021-06-01
This invention relates to indolizine derivatives and their use in medicine. In particular, the present invention discloses novel substituted indolizine derivatives of formula I, or an isotopically labeled compound thereof, or an optical isomer thereof, a geometric isomer thereof, a tautomer thereof or a mixture of various isomers, or a pharmaceutically acceptable salt thereof, or a prodrug thereof. The invention also relates to the use of these compounds in medicine.
本发明涉及吲哚利嗪衍生物及其在医学中的应用。特别是,本发明公开了式 I 的新型取代吲哚利嗪衍生物,或其同位素标记的化合物,或其光学异构体、几何异构体、同分异构体或各种异构体的混合物,或其药学上可接受的盐,或其原药。本发明还涉及这些化合物在医学中的用途。